Cetuximab Reduces the Accumulation of Radiolabeled Bevacizumab in Cancer Xenografts without Decreasing VEGF Expression-Reference-Cited by-同舟云学术

Cetuximab Reduces the Accumulation of Radiolabeled Bevacizumab in Cancer Xenografts without Decreasing VEGF Expression

Published:2014-10-17 Issue:11 Volume:11 Page:4249-4257
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Heskamp Sandra,Boerman Otto C.,Molkenboer-Kuenen Janneke D. M.,Sweep Fred C. G. J.,Geurts-Moespot Anneke,Engelhardt Mallory S.,van der Graaf Winette T. A.,Oyen Wim J. G.,van Laarhoven Hanneke W. M.¹

Affiliation:

1. Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp500460g

Reference33 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors

2. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

3. Cetuximab for the Treatment of Colorectal Cancer

4. Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

5. Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual inhibition of EGFR and c-Src by cetuximab and dasatinib combined with FOLFOX chemotherapy in patients with metastatic colorectal cancer;Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies;2023

2. Improving Biologics’ Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures;Cancers;2021-09-15

3. Precise engineering of cetuximab encapsulated gadollium nanoassemblies: in vitro ultrasound diagnosis and in vivo thyroid cancer therapy;Drug Delivery;2021-01-01

4. Imiter la réponse immunitaire humorale polyclonale;médecine/sciences;2019-12

5. Combination of Anti-angiogenics and Other Targeted Therapies;Tumor Angiogenesis;2019